Secondary Breast Reconstruction with Fat Grafting

Sponsorship Statement: This continuing medical education activity is sponsored by .

Support Statement: There is no commercial support for this activity.

Target Audience: The intended audience for this activity is plastic surgeons and other healthcare professionals involved in treatment of plastic surgery patients.

Learning Objectives: At the conclusion of this activity participants should be able to:

1. Understand the indications for fat grafting to the reconstructed breast.
2. Explain the surgical technique of fat grafting to the reconstructed breast.
3. Understand the expected volume retention after fat grafting to the reconstructed breast.

Faculty:
Nolan S. Karp, MD
Associate Professor and Service Chief
Department of Plastic Surgery
New York University Langone Medical Center

External Reviewer:
Seth R. Thaller, MD, DMD, FACS (Planning Committee)

This enduring material is approved for 1 year from the date of release, January 13, 2014 to January 12, 2015.

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
Nolan S. Karp, MD
Contracted Research: Allergan

External Reviewer reports the following relationship(s):
Seth R. Thaller, MD, DMD, FACS (Planning Committee)
No relevant financial relationships to disclose.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.